YDES - YD Bio Limited Ordinary Shares
Price:
--
--
| Metric | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | |||||||
| R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A Expenses | 0.4 | 0.4 | 0.4 | 0.3 | 0.5 | 1.0 | 0.5 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 0.4 | 0.4 | 0.4 | 0.3 | 0.5 | 1.0 | 0.5 |
| Operating Income | |||||||
| Operating Income | (0.4) | (0.4) | (0.4) | (0.3) | (0.5) | (1.0) | (0.5) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 |
| Profitability | |||||||
| EBITDA | (2.2) | (3.4) | 0.4 | 2.2 | 17.1 | (22.0) | 0.7 |
| EBIT | (2.2) | (3.4) | 0.4 | 2.2 | 17.1 | (22.0) | 0.7 |
| Income Before Tax | (2.2) | (3.4) | 0.4 | 2.2 | 17.1 | (22.0) | 0.7 |
| Income Tax Expense | (0.0) | 0.0 | 0 | (0.0) | 0.0 | 0.0 | (0.0) |
| Net Income | (2.2) | (3.4) | 0.4 | 2.2 | 17.1 | (22.0) | 0.7 |
| Per Share Data | |||||||
| EPS (Basic) | -0.65 | -0.98 | 0.10 | 0.54 | 4.05 | -5.12 | 0.16 |
| EPS (Diluted) | -0.65 | -0.98 | 0.10 | 0.54 | 4.05 | -5.12 | 0.16 |
| Shares Outstanding | 3.4 | 3.4 | 4.0 | 4.0 | 4.2 | 4.3 | 4.3 |
| Metric | 2026 Q2 | 2025 Q4 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||
| Cash & Cash Equivalents | 2.7 | 6.0 | 0.0 | 0.0 | 3.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 0.6 | 0.7 | 0.1 | 0.1 | 0.3 | 0.1 | 0.1 | 0.0 | 0.0 |
| Inventory | 1.9 | 1.9 | 0 | 0 | 0.0 | 0 | 0 | 0 | 0.1 |
| Other Current Assets | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.1) |
| Total Current Assets | 5.6 | 9.7 | 0.2 | 0.2 | 3.5 | 0.2 | 0.3 | 0.2 | 0.3 |
| Non-Current Assets | |||||||||
| Property, Plant & Equipment | 0.1 | 0.1 | 0 | 0 | 0.1 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 2.5 | 2.6 | 0 | 0 | 2.7 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 2.8 | 3.3 | 10.5 | 10.6 | 10.4 | 13.3 | 13.0 |
| Other Non-Current Assets | 1.9 | 1.4 | 0 | 0 | (9.9) | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 4.5 | 4.1 | 2.8 | 3.3 | 3.4 | 10.6 | 10.4 | 13.3 | 13.0 |
| Total Assets | 10.1 | 13.8 | 3.0 | 3.5 | 6.9 | 10.8 | 10.7 | 13.5 | 13.2 |
| Current Liabilities | |||||||||
| Account Payables | 0.4 | 0.4 | 0 | 0 | 0.0 | 0 | 0 | 0 | 0.0 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0.0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0.2 | 0.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 11.1 | 10.8 | 17.7 | 10.1 | 9.9 | 9.2 | 7.8 |
| Total Current Liabilities | 1.1 | 1.6 | 11.2 | 10.8 | 0.3 | 10.1 | 9.9 | 9.2 | 8.1 |
| Non-Current Liabilities | |||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0.0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 4.5 | 15.0 | 7.8 | 5.9 | 0.0 | 3.6 | 5.9 | 23.3 | 2.2 |
| Total Non-Current Liabilities | 4.5 | 15.0 | 7.8 | 5.9 | 0.0 | 3.6 | 5.9 | 23.3 | 2.2 |
| Total Liabilities | 5.6 | 16.6 | 19.0 | 16.8 | 0.3 | 13.6 | 15.8 | 32.6 | 10.3 |
| Stockholders' Equity | |||||||||
| Common Stock | 0.0 | 0.0 | 2.7 | 3.2 | 0.1 | 10.5 | 10.3 | 13.2 | 12.6 |
| Retained Earnings | (3.5) | (10.2) | (18.7) | (16.4) | (1.9) | (13.3) | (15.3) | (32.2) | (9.7) |
| Accumulated Other Comprehensive Income | 0.1 | 0.2 | 0 | 0 | 0.0 | 0 | 0 | 0 | 0 |
| Total Stockholders' Equity | 4.5 | (2.9) | (16.1) | (13.2) | 6.6 | (2.9) | (5.1) | (19.0) | 3.0 |
| Total Liabilities & Equity | 10.1 | 13.8 | 3.0 | 3.5 | 6.9 | 10.8 | 10.7 | 13.5 | 13.2 |
| Debt Metrics | |||||||||
| Total Debt | 0.0 | 0.0 | 0 | 0 | 0.0 | 0 | 0 | 0 | 0 |
| Net Debt | (2.7) | (6.0) | (0.0) | (0.0) | (3.1) | (0.0) | (0.0) | (0.0) | (0.0) |
| Metric | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (2.2) | (3.4) | 0.4 | 2.2 | 17.1 | (22.0) | 0.7 |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 0.1 | (0.1) | 0.0 | 0.2 | (0.0) | 0.4 | (0.2) |
| Other Non-Cash Items | 1.8 | 3.0 | (0.8) | (2.4) | (17.6) | 21.0 | (1.2) |
| Operating Cash Flow | (0.3) | (0.5) | (0.4) | (0.0) | (0.6) | (0.6) | (0.7) |
| Investing Activities | |||||||
| Capital Expenditure | 0 | (0.0) | 0 | 0 | (0.0) | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (0.0) | (0.1) | (0.1) | (0.1) | (0.1) | (0.1) | (0.1) |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0.6 | 7.4 | 0.3 | 0 | 3.1 | 0 | 0 |
| Investing Cash Flow | 0.6 | 7.3 | 0.2 | (0.1) | 3.1 | (0.1) | (0.1) |
| Financing Activities | |||||||
| Net Debt Issuance | 0.3 | 0.5 | 0.3 | 0.0 | 0.7 | 0.8 | 0.6 |
| Stock Repurchased | (0.6) | (7.4) | 0 | 0 | (3.1) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | (0.3) | (6.9) | 0.3 | 0.0 | (2.4) | 0.8 | 0.6 |
| Cash Position | |||||||
| Net Change in Cash | 0.0 | (0.1) | 0.1 | (0.0) | 0.0 | 0.0 | (0.2) |
| Cash at Beginning | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 |
| Cash at End | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Free Cash Flow | (0.3) | (0.5) | (0.4) | (0.0) | (0.6) | (0.6) | (0.7) |
| Key Metrics | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | ||
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Operating Income | (0.4) | (0.4) | (0.4) | (0.3) | (0.5) | (1.0) | (0.5) | ||
| Net Income | (2.2) | (3.4) | 0.4 | 2.2 | 17.1 | (22.0) | 0.7 | ||
| EPS (Diluted) | -0.65 | -0.98 | 0.10 | 0.54 | 4.05 | -5.12 | 0.16 | ||
| Balance Sheet | |||||||||
| Cash & Equivalents | 2.7 | 6.0 | 0.0 | 0.0 | 3.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total Assets | 10.1 | 13.8 | 3.0 | 3.5 | 6.9 | 10.8 | 10.7 | 13.5 | 13.2 |
| Total Debt | 0.0 | 0.0 | 0 | 0 | 0.0 | 0 | 0 | 0 | 0 |
| Stockholders' Equity | 4.5 | (2.9) | (16.1) | (13.2) | 6.6 | (2.9) | (5.1) | (19.0) | 3.0 |
| Cash Flow | |||||||||
| Operating Cash Flow | (0.3) | (0.5) | (0.4) | (0.0) | (0.6) | (0.6) | (0.7) | ||
| Capital Expenditure | 0 | (0.0) | 0 | 0 | (0.0) | 0 | 0 | ||
| Free Cash Flow | (0.3) | (0.5) | (0.4) | (0.0) | (0.6) | (0.6) | (0.7) | ||